AEON Biopharma, Inc. financial statements
AEON Biopharma, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 39.22M | 10-K |
| Cash and equivalents | USD 3.01M | 10-Q |
| Total debt | USD 35.74M | EODHD |
AEON Biopharma, Inc. financials on 6ix · AEON Biopharma, Inc. on 6ix